ConexiantDigital CBT Outperforms Psychoeducation in Generalized Anxiety Disorder 

Smartphone-delivered CBT achieved 71% remission in GAD patients at 10 weeks, more than doubling remission rates compared to psychoeducation. A 351-patient RCT with blinded evaluators confirms benefits sustained through 24 weeks, including improvements in depression, sleep, and clinician-rated anxiety.

Clinical Considerations

• DCBT remission rate (71%) was twice that of psychoeducation (34.6%) at 10 weeks, with gains sustained and widening at 24 weeks (77.7% vs. 52.0%)
• Dose-response relationship confirmed: patients completing more lessons showed greater symptom reduction, supporting structured engagement protocols
• Trial used blinded independent evaluators and a credible active control, strengthening confidence in findings beyond typical digital health evidence
• Benefits extended to depressive symptoms and sleep quality, making DCBT relevant across comorbid presentations common in psychiatric practice

Practice Applications

• Prescribe smartphone-based DCBT as a first-line adjunct for GAD patients facing waitlists or access barriers
• Integrate DCBT into stepped-care models before or alongside clinician-delivered therapy
• Monitor lesson completion as a proxy for engagement and expected treatment response
• Counsel patients that self-directed digital CBT has RCT-level evidence, not just app-store claims

More in Telehealth